Fundz

Antiva Biosciences Strengthens Leadership with Key New Appointments

PRIVATEOct 19, 2023

Position

Chief Medical Officer

Company

Antiva Biosciences

Elaine Chien
echien@antivabio.com
Redwood CityBiotechnologyScience And Engineering

Description

Antiva Biosciences, a biopharmaceutical company developing novel, topical therapeutics for the treatment of high-risk infections and pre-cancerous lesions caused by human papilloma virus , today announced several key new appointments designed to strengthen the company's leadership as it continues to advance its lead development candidate, ABI-2280. The company has added Elaine Chien, M.D., FACOG, as chief medical officer, Susan Wilson, Ph.D., as vice president of project management and strategic initiatives, and Rajashree Joshi-Hangal, Ph.D., as vice president of technical operations. Collectively, these individuals bring Antiva significant industry experience in areas directly related to the company's ongoing work in developing innovative treatments for diseases caused by HPV infection.

Quick answer

Antiva Biosciences Strengthens Leadership with Key New Appointments (October 19, 2023). Antiva Biosciences is based in Redwood City, California, United States.

What did Antiva Biosciences announce on October 19, 2023?
Antiva Biosciences, a biopharmaceutical company developing novel, topical therapeutics for the treatment of high-risk infections and pre-cancerous lesions caused by human papilloma virus , today announced several key new appointments designed to strengthen the company's leadership as it continues to advance its lead development candidate, ABI-2280. The company has added Elaine Chien, M.D., FACOG, as chief medical...
What does Antiva Biosciences do?
Antiva Biosciences, Inc. is a clinical stage biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection.
Where is Antiva Biosciences based?
Antiva Biosciences is based in Redwood City, California, United States.
Which similar companies made leadership changes around the same time?
Bio-Techne Corporation (October 21, 2023), EmeritusDX (October 30, 2023), Emmes (October 2, 2023) and AnHeart Therapeutics (September 28, 2023) also announced leadership changes within 45 days of Antiva Biosciences.

Source: Fundz verified event record.

Other recent leadership changes in Science And Engineering and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Antiva Biosciences, and when

A new leader at Antiva Biosciences brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Antiva Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Antiva Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Antiva Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Antiva Biosciences

Location

555 Twin Dolphin Drive, Suite 620

Redwood City, California, United States

About

Antiva Biosciences, Inc. is a clinical stage biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. We aim to stop cancer before it starts by treating the pre-cancerous lesions caused by HPV. Our lead programs are in clinical trials in high grade anal intraepithelial neoplasias (AIN 2,3) and high grade cervical intraepithelial neoplasias (CIN 2,3). The company was founded as Hera Therapeutics in 2012 by Dr. Karl Hostetler at The University of California San Diego and builds on his anti-viral expertise as co-founder of Triangle Pharmaceuticals and Chimerix. Antiva’s chemistry platform has yielded over two hundred proprietary pro-drug compounds that are designed to enhance the therapeutic index of known, potent antivirals.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Antiva Biosciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Gail
Senior decision-maker at this company
••••••••@••••••••

See Gail's verified email →

Susan
Likely contact at this company
••••••••@••••••••

See Susan's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Antiva Biosciences's next move

Learn about Strategic plan

Antiva Biosciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.